icad Inc (ICAD)
1.47
-0.02
(-1.34%)
USD |
NASDAQ |
May 03, 16:00
1.50
+0.03
(+2.04%)
After-Hours: 20:00
icad Enterprise Value: 17.07M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 17.07M |
May 02, 2024 | 17.60M |
May 01, 2024 | 16.02M |
April 30, 2024 | 16.02M |
April 29, 2024 | 17.33M |
April 26, 2024 | 17.07M |
April 25, 2024 | 17.33M |
April 24, 2024 | 19.44M |
April 23, 2024 | 19.44M |
April 22, 2024 | 18.39M |
April 19, 2024 | 18.92M |
April 18, 2024 | 20.23M |
April 17, 2024 | 19.44M |
April 16, 2024 | 20.50M |
April 15, 2024 | 21.29M |
April 12, 2024 | 22.87M |
April 11, 2024 | 23.13M |
April 10, 2024 | 23.40M |
April 09, 2024 | 25.77M |
April 08, 2024 | 21.29M |
April 05, 2024 | 20.76M |
April 04, 2024 | 21.29M |
April 03, 2024 | 28.40M |
April 02, 2024 | 20.50M |
April 01, 2024 | 18.39M |
Date | Value |
---|---|
March 28, 2024 | 20.76M |
March 27, 2024 | 20.50M |
March 26, 2024 | 19.84M |
March 25, 2024 | 19.18M |
March 22, 2024 | 20.50M |
March 21, 2024 | 20.50M |
March 20, 2024 | 19.18M |
March 19, 2024 | 18.12M |
March 18, 2024 | 17.60M |
March 15, 2024 | 20.23M |
March 14, 2024 | 20.76M |
March 13, 2024 | 25.77M |
March 12, 2024 | 23.92M |
March 11, 2024 | 24.58M |
March 08, 2024 | 28.14M |
March 07, 2024 | 28.40M |
March 06, 2024 | 29.98M |
March 05, 2024 | 29.98M |
March 04, 2024 | 38.02M |
March 01, 2024 | 27.61M |
February 29, 2024 | 25.50M |
February 28, 2024 | 24.71M |
February 27, 2024 | 19.71M |
February 26, 2024 | 19.44M |
February 23, 2024 | 15.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.000M
Minimum
Mar 28 2023
489.67M
Maximum
Mar 31 2021
141.88M
Average
118.82M
Median
Jan 14 2022
Enterprise Value Benchmarks
ClearPoint Neuro Inc | 145.16M |
Perspective Therapeutics Inc | 1.055B |
Xtant Medical Holdings Inc | 126.76M |
Asensus Surgical Inc | 44.48M |
Catheter Precision Inc | 0.8601M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 2.055M |
Revenue (Quarterly) | 4.74M |
Total Expenses (Quarterly) | 5.457M |
EPS Diluted (Quarterly) | 0.05 |
Gross Profit Margin (Quarterly) | 91.18% |
Profit Margin (Quarterly) | 43.35% |
Earnings Yield | -14.97% |
Normalized Earnings Yield | -19.05 |